Intensity Therapeutics INTS
NASDAQ INTS
$3.28 -0.01 (-0.30%)
As of: Oct 20, 2026 · 3:59 PM EDT

Intensity Therapeutics (INTS) Change in Other Operating Assets (2022 - 2026)

Updated

Analysis

Intensity Therapeutics (INTS) Change in Other Operating Assets (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -950.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 188.00 Mn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 13.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Intensity Therapeutics 8.93 Mn -29.83 Mn - -47,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -47,000.00
Mar 31, 2026 -127,000.00
Dec 31, 2025 -331,000.00
Sep 30, 2025 297,000.00
Jun 30, 2025 98,000.00
Mar 31, 2025 -51,000.00
Dec 31, 2024 -205,000.00
Sep 30, 2024 61,000.00
Jun 30, 2024 445,000.00
Mar 31, 2024 -602,000.00
Dec 31, 2023 1.36 Mn
Sep 30, 2023 688,000.00
Jun 30, 2023 31,000.00
Mar 31, 2023 -10,000.00
Dec 31, 2022 -18,263.00
Sep 30, 2022 1,384.00
API Access

Intensity Therapeutics Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=INTS&period=max&api_key=YOUR_API_KEY